Radium and other alpha emitters in prostate cancer

(223)Radium ((223)Ra) is the first alpha-emitting therapy proven effective in human cancer. Prospective randomized trials indicate that (223)Ra, which concentrates after intravenous injection in areas of osteoblastic metastatic disease, can prolong survival in bone-dominant castrate resistant prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartor, Oliver, Sharma, Deepali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043743/
https://www.ncbi.nlm.nih.gov/pubmed/30050802
http://dx.doi.org/10.21037/tau.2018.02.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043743/
https://www.ncbi.nlm.nih.gov/pubmed/30050802
http://dx.doi.org/10.21037/tau.2018.02.07

Ejemplares similares